007390 — NatureCell Co Balance Sheet
0.000.00%
- KR₩2tn
- KR₩2tn
- KR₩32bn
Annual balance sheet for NatureCell Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 48,497 | 32,551 | 31,256 | 29,892 | 28,371 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,203 | 6,022 | 30,663 | 4,927 | 10,477 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 56,334 | 42,901 | 67,163 | 40,622 | 42,039 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9,334 | 8,531 | 9,606 | 13,467 | 13,876 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 85,750 | 69,650 | 94,021 | 68,399 | 71,998 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 20,518 | 6,578 | 35,752 | 4,214 | 4,124 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 23,068 | 8,805 | 36,863 | 6,979 | 7,373 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 62,682 | 60,845 | 57,158 | 61,419 | 64,624 |
Total Liabilities & Shareholders' Equity | 85,750 | 69,650 | 94,021 | 68,399 | 71,998 |
Total Common Shares Outstanding |